Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: mlkr who wrote (2955)	6/21/2010 11:20:25 AM
From: lindalib	Respond to of 3722

Wow, you're really digging on your DD. In ARWR (again) at 1.27.

To: mlkr who wrote (2955)	6/22/2010 1:57:44 PM
From: Jibacoa	1 Recommendation Read Replies (2) \| Respond to of 3722

Re: ARWR After the sell off on June 17 at 12:55pm, the L that day was $1.13 at 1:10pm.<g> The stock since then has been able to stay above the support at the $1.20 level and resistance is now at $1.30 <g> bigcharts.marketwatch.com The stock is very speculative, but seems to have potential.<g> My cost on the shares I have left is $0.50 so I can wait for further developments. ARWR is scheduled to join the Russell Microcap Index this Friday. Back on Apr7, Nobel Laureate, Dr. Lelland Hartwell joined its Board of Advisors. And on Apr26,previous Commissioner of the FDA,Dr. Andrew von Eschenbach, also joined its Scientific Advisory Board.<g> But as mentioned, it seems prudent to wait for ARWR to regain its UT, after that, it still has plenty of room to run.<G> bigcharts.marketwatch.com Bernard